Published in Physician Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Medtronic, Inc.
Report 1: Dr. Ronald M. Fairman, principal investigator for the VALOR clinical study evaluating the Talent(TM) Thoracic Stent Graft System, today presented positive 12-month results at a late-breaking session during the annual meeting of the Society for Vascular Surgery in Baltimore. Sponsored by Medtronic (NYSE:MDT), VALOR is a prospective, multi-center study of 195 test group patients with thoracic aortic aneurysms who were considered candidates for open surgical repair. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.